


Wilder Fulford is an accomplished international M&A banker with over 20 years of experience at leading investment banks in the United States and Europe, specializing in healthcare and life sciences. He has advised on a wide range of strategic transactions, including buy-side and sell-side M&A, joint ventures, licensing agreements, co-development partnerships, acquisition financing, equity private placements, and public company deals, as well as managing hostile transactions in both defensive and offensive capacities. Since 2015, he has been the Founder and Managing Director of The Fulford Group, an independent M&A advisory and corporate finance firm providing strategic guidance to boards, executives, and entrepreneurs in the global healthcare and life sciences industries. He also serves as an Operating Partner at Quadria Capital, a $1.5 billion healthcare focused private equity firm, where he helps drive investments across the Asia Pacific region, and sits on the board of Straits Orthopaedics. Previously, he held senior roles at Deutsche Bank, Bank of America, Merrill Lynch, Torreya Partners, and Salomon Brothers, and holds a Ph.D. in Molecular Biology from The Rockefeller University and a B.Sc. in Biochemistry and English from the University of Toronto.
Wilder Fulford is an accomplished international M&A banker with over 20 years of experience at leading investment banks in the United States and Europe, specializing in healthcare and life sciences. He has advised on a wide range of strategic transactions, including buy-side and sell-side M&A, joint ventures, licensing agreements, co-development partnerships, acquisition financing, equity private placements, and public company deals, as well as managing hostile transactions in both defensive and offensive capacities. Since 2015, he has been the Founder and Managing Director of The Fulford Group, an independent M&A advisory and corporate finance firm providing strategic guidance to boards, executives, and entrepreneurs in the global healthcare and life sciences industries. He also serves as an Operating Partner at Quadria Capital, a $1.5 billion healthcare focused private equity firm, where he helps drive investments across the Asia Pacific region, and sits on the board of Straits Orthopaedics. Previously, he held senior roles at Deutsche Bank, Bank of America, Merrill Lynch, Torreya Partners, and Salomon Brothers, and holds a Ph.D. in Molecular Biology from The Rockefeller University and a B.Sc. in Biochemistry and English from the University of Toronto.
Wilder Fulford is an accomplished international M&A banker with over 20 years of experience at leading investment banks in the United States and Europe, specializing in healthcare and life sciences. He has advised on a wide range of strategic transactions, including buy-side and sell-side M&A, joint ventures, licensing agreements, co-development partnerships, acquisition financing, equity private placements, and public company deals, as well as managing hostile transactions in both defensive and offensive capacities. Since 2015, he has been the Founder and Managing Director of The Fulford Group, an independent M&A advisory and corporate finance firm providing strategic guidance to boards, executives, and entrepreneurs in the global healthcare and life sciences industries. He also serves as an Operating Partner at Quadria Capital, a $1.5 billion healthcare focused private equity firm, where he helps drive investments across the Asia Pacific region, and sits on the board of Straits Orthopaedics. Previously, he held senior roles at Deutsche Bank, Bank of America, Merrill Lynch, Torreya Partners, and Salomon Brothers, and holds a Ph.D. in Molecular Biology from The Rockefeller University and a B.Sc. in Biochemistry and English from the University of Toronto.
FUND 1
Name of AIF: Healthquad Fund
Name of Scheme: Healthquad Fund I
Category: Category I – Venture Capital Fund
Registration no.: IN/AIF1/16-17/0216
Fund Manager Name: Healthquad Advisors Private Limited
FUND 2
Name of AIF: Healthquad Trust II
Name of Scheme: Healthquad Fund II
Category: Category II – Alternative Investment Fund
Registration no.: IN/AIF2/19-20/0684
Fund Manager Name: Healthquad Capital Advisors Private Limited
FUND 3
Name of AIF: Healthquad Trust III
Name of Scheme: Healthquad Fund III
Category: Category II AIF
Registration number: IN/AIF2/23-24/1445
Fund manager: Healthquad Advisors Private Limited
© 2026 HealthQuad
FUND 1
Name of AIF: Healthquad Fund
Name of Scheme: Healthquad Fund I
Category: Category I – Venture Capital Fund
Registration no.: IN/AIF1/16-17/0216
Fund Manager Name: Healthquad Advisors Private Limited
FUND 2
Name of AIF: Healthquad Trust II
Name of Scheme: Healthquad Fund II
Category: Category II – Alternative Investment Fund
Registration no.: IN/AIF2/19-20/0684
Fund Manager Name: Healthquad Capital Advisors Private Limited
FUND 3
Name of AIF: Healthquad Trust III
Name of Scheme: Healthquad Fund III
Category: Category II AIF
Registration number: IN/AIF2/23-24/1445
Fund manager: Healthquad Advisors Private Limited
© 2026 HealthQuad
FUND 1
Name of AIF: Healthquad Fund
Name of Scheme: Healthquad Fund I
Category: Category I – Venture Capital Fund
Registration no.: IN/AIF1/16-17/0216
Fund Manager Name: Healthquad Advisors Private Limited
FUND 2
Name of AIF: Healthquad Trust II
Name of Scheme: Healthquad Fund II
Category: Category II – Alternative Investment Fund
Registration no.: IN/AIF2/19-20/0684
Fund Manager Name: Healthquad Capital Advisors Private Limited
FUND 3
Name of AIF: Healthquad Trust III
Name of Scheme: Healthquad Fund III
Category: Category II AIF
Registration number: IN/AIF2/23-24/1445
Fund manager: Healthquad Advisors Private Limited
© 2026 HealthQuad